ESR1 and breast carcinoma: Through analyzing PpIX fluorescence in a panel of human breast cancer cells including ER-positive, HER2-positive and TNBC cells treated with PpIX precursor ALA, we observed a heterogeneity in PpIX fluorescence within and between different types of breast cancer cells.